ALCAM and osteosarcoma: Additionally, FSTL1 knockdown in osteosarcoma inhibits proliferation, invasion, spheroid formation, and ALCAM expression, while anti-FSTL1 treatment restores NK cell activity, killing tumor cells and inhibiting osteosarcoma growth and metastasis [38].